Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 19,000 shares at $149.18 ($2.8M) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Open-market sale of $2.8M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $145.16 | 3,583 | $520K | 18.8% |
| 2 | $145.16 | 3,583 | $520K | 18.8% |
| 3 | $145.96 | 4,083 | $596K | 21.5% |
| 4 | $145.96 | 4,083 | $596K | 21.5% |
| 5 | $146.92 | 1,334 | $196K | 7.1% |
| 6 | $146.92 | 1,334 |
| $196K |
| 7.1% |
| 7 | $148.04 | 500 | $74K | 2.7% |
| 8 | $149.18 | 500 | $75K | 2.7% |
| Total | $145.93 avg | 19,000 | $2.8M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |